1180158-99-9
英文名稱
7H-Pyrrolo[2,3-d]pyrimidin-2-amine, 7-[3,5-difluoro-4-(4-morpholinylmethyl)phenyl]-N-[6-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-3-pyridinyl]-, rel-
CAS
1180158-99-9
分子式
C28H32F2N8O
分子量
534.6
MOL 文件
1180158-99-9.mol
1180158-99-9 結(jié)構(gòu)式
基本信息
英文別名
7H-Pyrrolo[2,3-d]pyrimidin-2-amine, 7-[3,5-difluoro-4-(4-morpholinylmethyl)phenyl]-N-[6-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-3-pyridinyl]-, rel-應(yīng)用領(lǐng)域
用途一
BVB-808 is a selective Jak2 type 1 inhibitor. Janus kinases are critical components of signaling pathways that regulate hematopoiesis. Mutations of the non-receptor tyrosine kinase JAK2 are found in many BCR-ABL-negative myeloproliferative neoplasms. Preclinical results support that JAK2 inhibitors could show efficacy in treating chronic myeloproliferative neoplasms. JAK2 has also been postulated to play a role in BCR-ABL signal transduction. Therefore, inhibitors of JAK2 kinases are turning into therapeutic strategies for treatment of chronic myelogenous leukemia (CML).